About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Does Penny Stock CYREN Belong in Your Portfolio?
Israel-based cybersecurity company Cyren (CYRN) boasts a broad consumer base and has been completing several product developments with the help of Cyber Inbox Security. However, CYRN’s shares have declined in price over the past few months. So, let’s evaluate if it is wise to scoop up its shares now. Read on.
Consider Adding LM Funding America to Your Portfolio, Here’s Why
Finance company LM Funding America’s (LMFA) shares have surged with soaring bitcoin prices over the past few months. Moreover, the company reported impressive financials for the second quarter. So read on to learn why it could be wise to add the stock to one’s portfolio now.
5 Reasons Why OneMain Holdings is a Screaming Buy
Financial services company OneMain Holdings (OMF) reported impressive second-quarter results and paid a $4.20 per share dividend in August 2021. Furthermore, we think the stock possesses solid value and growth attributes and, as such, may now be an attractive buy. Read on.
Is the Pullback in Roblox an Opportunity or Warning Sign?
The recent success of Squid Game helped online entertainment platform operator Roblox (RBLX) grab the market’s attention. However, the company’s stock has declined in price over the past few months as schools have reopened and children have returned to outdoor activities. So, is it wise to buy the stock now, or is there further downside in the offing? Let’s find out.
Should You Buy Marrone Bio Innovations Under $1?
The shares of bio-based pest management and plant health products provider Marrone Bio Innovations’ (MBII) have declined in price over the past few months amid challenging weather conditions and supply chain constraints. So, the question becomes, is it wise to buy the stock now as the company advances three novel bioherbicides? Let’s find out.
Is ChargePoint Holdings a Buy Under $20?
Shares of popular electric vehicle (EV) charging network provider ChargePoint Holdings (CHPT) have declined significantly over the past few months, even though the company completed several acquisitions and expanded its reach in Europe. Let’s find out if it is wise to buy the stock trading below $20?
Is IronNet a Buy Under $15?
Shares of cybersecurity company IronNet (IRNT) have declined significantly since hitting its 52-week high of $47.50 on September 16. The stock is currently trading below $15. Can the stock rebound as the company expands its reach? Read more to find out.
Buy the Dip in Vale, Here’s Why
One of the largest iron ore producers in the world, Vale’s (VALE) shares have plunged significantly from its 52-week high of $23.18, which it hit on June 25, 2021. However, it could be wise to buy the dip in the stock because of its solid financials. Read on for details.
Should You Buy the Dip in Palantir?
Even though big data analytics company Palantir (PLTR) has made several developments over the past few months, it reported losses in the second quarter and is currently trading significantly below its 52-week high. So, let’s find out if it is wise to buy the dip in the stock.